Daxor Announces the Receipt of Signed Agreement from Arkansas Heart Hospital, Part of the MedCath System.NEW YORK New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of -- Daxor Corporation, (AMEX AMEX See: American Stock Exchange :DXR DXR Danbury Municipal Airport, Danbury CT (airport code) DXR Data Extraction and Recording DXR X-Director DXR Dynamic Extended Resolution ): a medical instrumentation and biotechnology company, today announced the receipt of a signed agreement from the Arkansas Heart Hospital of Little Rock Arkansas. Arkansas Heart Hospital is a specialty hospital designed to provide diagnosis and treatment of heart disease. The hospital provides comprehensive inpatient and outpatient cardiac care, and staffs a 24-hour full service Emergency Center. Arkansas Heart Hospital was designed to provide the best possible setting for the diagnosis and treatment of cardiovascular disease. The stated mission of the Arkansas Heart Hospital is, in partnership with their physicians and employees, to deliver state of the art cardiovascular care in a professional manner; constantly improve their clinical skills; provide their services in a supportive, team environment; and to carry on educational activities related to promotion of health in the community. The hospital is the second hospital in the state of Arkansas to obtain a Blood Volume Analyzer. MedCath, of Charlotte, North Carolina “Charlotte” redirects here. For other uses, see Charlotte (disambiguation). Charlotte is the largest city in the state of North Carolina and the 20th largest city in the United States. , is an operator of specialized cardiology facilities and manages Arkansas Heart Hospital in partnership with local physicians. The heart hospital is a medical first for Arkansas, and only the second of its kind in the nation. A report in the American Journal of Cardiology (May 2004) in congestive heart failure congestive heart failure, inability of the heart to expel sufficient blood to keep pace with the metabolic demands of the body. In the healthy individual the heart can tolerate large increases of workload for a considerable length of time. patients followed for 2 years at the Columbia Presbyterian Medical Center in New York reported a 55% death rate after 2 years in patients who had hypervolemia (too much blood) as compared to a 0% death rate for patients with a normal or slightly reduced blood volume. This remarkable study utilizing the Blood Volume Analyzer provides strong evidence that appropriate treatment which results in normalization In relational database management, a process that breaks down data into record groups for efficient processing. There are six stages. By the third stage (third normal form), data are identified only by the key field in their record. of a patient's blood volume can significantly improve life expectancy. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with a single use diagnostic kit. It is the first FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved instrument to provide rapid, direct measurement of a patient's blood volume with a high degree of precision. Among nationally renowned hospitals that have purchased the BVA-100 Blood Volume Analyzer are the Cleveland Clinic, The Mayo Clinic and NYU NYU New York University NYU New York Undercover (TV show) Medical Center, as well as other major medical institutions. More information about the BVA-100 and other Daxor products and services can be found at www.daxor.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion